GPX3 and pulmonary arterial hypertension: The group of SSc-PAH patients displayed the lowest Se status, i.e., significantly reduced concentrations of Se (Figure 2A), and SELENOP (Figure 2B), as well as reduced GPx3 activity (Figure 2C).